Incidence of Bevacizumab‐Associated Toxicity in Children With Low‐Grade Glioma With and Without Neurofibromatosis Type 1
HTN is more common than previously reported in both NF1 and non-NF1 patients treated with BVZ for LGG, but reversible. Blood pressure should be monitored and treated appropriately. BVZ appears to be a safe and efficacious therapeutic option for young patients with NF1-related optic glioma.
Authors
- Gilad Hamdani (ORCID: https://orcid.org/0000-0002-1009-5088)
- Alexander Yelak
- Helen Toledano
- Orli Michaeli (ORCID: https://orcid.org/0000-0002-6097-6457)
- Amit Dagan
- Gad Dotan
Institutions
- Tel Aviv University (IL)
- Schneider Children's Medical Center (IL)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2025-12-22
- DOI
- https://doi.org/10.1002/1545-5017.70059
- Primary Topic
- Neurofibromatosis and Schwannoma Cases
- Type
- article
- Field-Weighted Citation Impact
- 0.00